Article
Author(s):
When a decision is made to prescribe a topical beta-blocker for monotherapy or as an add-on agent, timolol hemihydrate (Betimol, Santen) offers many advantages that may make it an excellent option.
ARVO announces Swathi Kaliki, MD, as recipient of 2025 Ludwig von Sallmann Clinician-Scientist Award
ROP: Treating and preventing blindness in preterm babies
The search for an antifibrotic drug for use with pediatric glaucoma devices
Managing a changing landscape of IRD pediatric cases
Hyperacute outer retinal dysfunction may be an underrecognized pediatric disorder
Study highlights strong parental cooperation in preschool vision screening